Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
boston top stories
clinical trials
life sciences
national blog main
national top stories
new york blog main
new york top stories
san francisco blog main
san francisco top stories
sanofi
2
×
abbvie
acceleron pharma
acid sphingomyelinase deficiency
allergan
alzheimer's disease
amgen
anika therapeutics
annovis bio
arcutis biotherapeutics
baricitinib
beam therapeutics
bill & melinda gates foundation
biofourmis
biointellisense
biotech
biotechnology industry organization
black diamond therapeutics
boehringer ingelheim
boulder/denver blog main
boulder/denver top stories
bruce goldsmith
cancer
cancer drug
cholesterol
chronic kidney disease
chronic rhinosinusitis
clostridoides-difficile
crispr
data
What
week
2
×
aces
announced
big
bio
black
ceo
cholesterol
companies
continue
debut
diamond
diamond’s
drug
flexible
inclisiran
indication
key
leading
life
lowering
mammoth
march
meant
medco
medicine
medicines
moves
nasdaq
ohana’s
open
passed
pop
pricing
roundup
science
steady
street
taken
test
Language
unset
2
×
Current search:
sanofi
×
unset
×
week
×
@xconomy.com
4 years ago
Bio Roundup: Mammoth Moves, Black Diamond’s Pop, Ohana’s Debut & More
@xconomy.com
4 years ago
As Cholesterol Drug Aces Big Test, MedCo CEO Open to Flexible Pricing
